Company Filing History:
Years Active: 2006-2010
Title: Innovations by Inventor Ching He
Introduction
Ching He, an accomplished inventor based in Newbury Park, California, has made significant contributions in the field of molecular biology and therapeutic applications. With a notable portfolio of four patents, He has dedicated his efforts to advancing healthcare through innovative solutions.
Latest Patents
Among his latest inventions is a patent titled "Chordin-like molecules and uses thereof." This invention focuses on Chordin-Like (CHL) polypeptides and the nucleic acid molecules encoding them. Other elements of the invention include selective binding agents, vectors, host cells, and methods for producing CHL polypeptides. Moreover, this patent encompasses pharmaceutical compositions and methodologies aimed at diagnosing, treating, ameliorating, and preventing diseases, disorders, and conditions associated with CHL polypeptides.
Career Highlights
Ching He is currently affiliated with Amgen Inc., a prominent biotechnology company that emphasizes innovative therapies and drug development. His work at Amgen underscores his commitment to translating scientific research into practical medical solutions.
Collaborations
He collaborates closely with notable coworkers like Naoki Nakayama and Duanzhi Wen. These partnerships enhance his research endeavors, fostering an environment of teamwork that drives innovation and accelerates progress in their projects.
Conclusion
Ching He's contributions to the field of molecular biology exemplify the power of innovation in addressing critical healthcare challenges. His patents and collaborative efforts at Amgen Inc. underline his dedication to improving patient outcomes through scientific advancements. As he continues to innovate, the impact of his work is expected to resonate throughout the medical community and beyond.